MedTrace Logo

Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

NCT01764308 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2019-04-17

No results posted yet for this study

Summary

60 patients receiving isotretinoin will be recruited from the UCLA acne specialty clinic. Subjects will be randomized in a 1:1 ratio to receive placebo or omega-3 1200mg twice a day for 24 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3

1200mg twice a day for 24 weeks

DIETARY_SUPPLEMENT

Placebo

4 tablets twice a day for 24 weeks

Sponsors & Collaborators

Principal Investigators

  • Christina N Kim, MD · Kaiser Permanente

  • Carolyn Goh, MD · UCLA Division of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764308 on ClinicalTrials.gov